Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Can J Physiol Pharmacol ; 96(4): 412-418, 2018 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-29378152

RESUMEN

Diabetes is one of the leading diseases worldwide and, thus, finding new therapeutic alternatives is essential. The development of non-alcoholic fatty liver disease is a notable diabetic complication. Therefore, antioxidant therapy became a leading topic in the world of diabetes research. The objective of this present study was to evaluate the effects of antioxidant N-acetylcysteine (NAC) administration on serum biochemical parameters and oxidative stress parameters in hepatic tissue of the diabetic rats. Thirty-two animals were divided in 4 groups (n = 8): G1, normal rats; G2, normal rats + NAC; G3, diabetic rats; and G4, diabetic rats + NAC. Diabetes was induced in diabetic groups through streptozotocin. NAC administration was effective in improving hyperglycemia and hypoinsulinemia, as well as reducing serum alanine-aminotransferase and urea, hepatic triglycerides accumulation, and oxidative stress biomarkers in the diabetic liver, as well as improving the activity of hepatic antioxidant enzymes. This effect was likely due to NAC's ability of restoring intracellular glutathione, an important compound for the antioxidant defense, as well as due to NAC's direct antioxidant properties. Thus, NAC administration was useful for reducing hepatic oxidative stress and decreased the deposit of triacylglycerols, minimizing diabetic hepatic damage, making it a promising therapeutic adjuvant in the future.


Asunto(s)
Acetilcisteína/uso terapéutico , Diabetes Mellitus Experimental/tratamiento farmacológico , Estrés Oxidativo , Acetilcisteína/farmacología , Animales , Antioxidantes/metabolismo , Biomarcadores/metabolismo , Diabetes Mellitus Experimental/sangre , Diabetes Mellitus Experimental/patología , Ácidos Grasos/metabolismo , Hiperglucemia/complicaciones , Hiperglucemia/tratamiento farmacológico , Insulina/sangre , Hígado/efectos de los fármacos , Hígado/enzimología , Hígado/patología , Masculino , Estrés Oxidativo/efectos de los fármacos , Ratas Wistar , Estreptozocina , Triglicéridos/metabolismo , Urea/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA